Mutant IDH1-IN-3 (Compound 1) is a selective allosteric inhibitor of mutant isocitrate dehydrogenase 1 ( IDH1 ). Mutant IDH1-IN-3 has an IC 50 of 13 nM for R132H IDH1 . Mutant IDH1-IN-3 inhibits the production of D-2-hydroxyglutaric acid ( 2HG ) in cells. Mutant IDH1-IN-3 can be used in the study of cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isocitrate Dehydrogenase (IDH)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.